These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 2996763

  • 1. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
    Yang L, Rowe TC, Liu LF.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763
    [Abstract] [Full Text] [Related]

  • 2. The mechanism of epipodophyllotoxin-induced thymocyte apoptosis: possible role of a novel Ca(2+)-independent protein kinase.
    Ye X, Georgoff I, Fleisher S, Coffman FD, Cohen S, Fresa KL.
    Cell Immunol; 1993 Oct 15; 151(2):320-35. PubMed ID: 8402939
    [Abstract] [Full Text] [Related]

  • 3. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
    Ross W, Rowe T, Glisson B, Yalowich J, Liu L.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5857-60. PubMed ID: 6094001
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1986 Aug 15; 46(8):3809-16. PubMed ID: 3015377
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
    Chow KC, Macdonald TL, Ross WE.
    Mol Pharmacol; 1988 Oct 15; 34(4):467-73. PubMed ID: 2845248
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K, Kohno K, Takano H, Sato S, Kiue A, Kuwano M.
    Cancer Res; 1990 Sep 15; 50(18):5819-24. PubMed ID: 2168282
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs.
    Kupfer G, Bodley AL, Liu LF.
    NCI Monogr; 1987 Sep 15; (4):37-40. PubMed ID: 2819729
    [Abstract] [Full Text] [Related]

  • 16. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Schwartz RE, Zwelling LA, Kerrigan D, Mattern MR, Charcosset JY, Jacquemin-Sablon A, Kohn KW.
    Cancer Res; 1986 Feb 15; 46(2):611-6. PubMed ID: 3000581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin.
    Kawada S, Yamashita Y, Fujii N, Nakano H.
    Cancer Res; 1991 Jun 01; 51(11):2922-5. PubMed ID: 1851667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.